Bellwether Advisors, LLC Gilead Sciences, Inc. Transaction History

Bellwether Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	BUY	$77.31 - $88.08 $77 - $88	1 Added 6.25%	17 $1,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $3,739 - $5,368	-60 Reduced 78.95%	16 $1,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $59 - $68	-1 Reduced 1.3%	76 $4,000
Q2 2022 Aug 05, 2022	SELL	$57.72 - $65.01 $15,295 - $17,227	-265 Reduced 77.49%	77 $4,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $22,066 - $23,807	326 Added 2037.5%	342 $23,000
Q4 2020 Jan 29, 2021	BUY	$56.65 - $64.55 $906 - $1,032	16 New	16 $0

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bellwether Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellwether Advisors, LLC with notifications on news.